Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin

Baicalin (baicalein-7-glucuronide) is a flavonoid purified from Scutellaria baicalensis Georgi that has traditionally been used for treatment of hypertension, cardiovascular diseases, and viral hepatitis. In this study, the effects of intestinal microbiota on the pharmacokinetics of baicalin were in...

Full description

Saved in:
Bibliographic Details
Published inArchives of pharmacal research Vol. 37; no. 3; pp. 371 - 378
Main Authors Kang, Mi Jeong, Ko, Gyu Sub, Oh, Do Gyeong, Kim, Jin Sung, Noh, Keumhan, Kang, Wonku, Yoon, Won Ki, Kim, Hyoung Chin, Jeong, Hye Gwang, Jeong, Tae Cheon
Format Journal Article
LanguageEnglish
Published Heidelberg Pharmaceutical Society of Korea 01.03.2014
대한약학회
Subjects
Online AccessGet full text
ISSN0253-6269
1976-3786
1976-3786
DOI10.1007/s12272-013-0179-2

Cover

More Information
Summary:Baicalin (baicalein-7-glucuronide) is a flavonoid purified from Scutellaria baicalensis Georgi that has traditionally been used for treatment of hypertension, cardiovascular diseases, and viral hepatitis. In this study, the effects of intestinal microbiota on the pharmacokinetics of baicalin were investigated in normal and antibiotic-pretreated rats following p.o. administration of 100 mg/kg baicalin by using liquid chromatography/ion trap mass spectrometry. When rats were pretreated orally with cefadroxil, oxytetracycline and erythromycin for 3 days to control the number of intestinal bacteria, the pharmacokinetic parameters of oral baicalin were significantly affected by antibiotics: C max , T 1/2(β) , K el and AUC values were significantly changed compared to those in normal rats. These results indicate that intestinal microbiota might play a key role in the oral pharmacokinetics of baicalin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000010.2014.37.3.015
ISSN:0253-6269
1976-3786
1976-3786
DOI:10.1007/s12272-013-0179-2